M&A Deal Summary |
|
|---|---|
| Date | 2024-04-02 |
| Target | Searchlight Pharma |
| Sector | Life Science |
| Buyer(s) | Apotex |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Bloom Burton & Co. (Financial) Davies Ward Phillips & Vineberg (Legal) |
SEARCH BY
Apotex is an independent pharmaceutical company committed to R&D, manufacturing, and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers, and governments worldwide. Apotex was founded in 1974 and is based in Toronto, Ontario.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Life Science M&A | 4 of 4 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Quebec M&A | 1 of 1 |
| Country: Canada M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-04-24 |
Aveva
Miramar, Florida, United States AVEVA is a transdermal drug delivery provider. The company provides pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents. Aveva was founded in 1991 and is based in Miramar, Florida. |
Sell | - |